HK1082762A1 - Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis - Google Patents
Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesisInfo
- Publication number
- HK1082762A1 HK1082762A1 HK06100885.2A HK06100885A HK1082762A1 HK 1082762 A1 HK1082762 A1 HK 1082762A1 HK 06100885 A HK06100885 A HK 06100885A HK 1082762 A1 HK1082762 A1 HK 1082762A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- polynucleotides encoding
- inhibiting angiogenesis
- encoding same
- antiangiogenic peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/643,219 US5801146A (en) | 1996-05-03 | 1996-05-03 | Compound and method for inhibiting angiogenesis |
US08/832,087 US5981484A (en) | 1996-05-03 | 1997-04-03 | Antiangiogenic peptides and methods for inhibiting angiogenesis |
HK99104850A HK1021191A1 (en) | 1996-05-03 | 1999-10-27 | Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1082762A1 true HK1082762A1 (en) | 2006-06-16 |
Family
ID=24579877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06100885.2A HK1082762A1 (en) | 1996-05-03 | 1999-10-27 | Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
Country Status (8)
Country | Link |
---|---|
US (2) | US5801146A (xx) |
JP (1) | JP4722989B2 (xx) |
AT (1) | ATE513908T1 (xx) |
CA (1) | CA2253243C (xx) |
CZ (1) | CZ300141B6 (xx) |
ES (1) | ES2367307T3 (xx) |
HK (1) | HK1082762A1 (xx) |
IL (2) | IL126626A (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945403A (en) * | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
US5837682A (en) * | 1996-03-08 | 1998-11-17 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US20020031518A1 (en) * | 1996-10-09 | 2002-03-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Plasminogen fragment having activity to inhibit tumor metastasis and growth and process for preparing same technical field |
EP1049934A1 (en) * | 1998-01-20 | 2000-11-08 | Abbott Laboratories | Specific antibodies to kringle 5 of apolipoprotein a and methods of use therefor |
IL140729A0 (en) * | 1998-07-14 | 2002-02-10 | Bristol Myers Squibb Co | Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof |
US7317003B2 (en) * | 1998-09-04 | 2008-01-08 | National University Of Singapore | Small peptides having anti-angiogenic and endothelial cell inhibition activity |
US6465424B1 (en) | 1999-02-17 | 2002-10-15 | Bristol-Myers Squibb Company | Anti-angiogenic agent and method for inhibiting angiogenesis |
EA003922B1 (ru) * | 1999-05-17 | 2003-10-30 | Конджачем, Инк. | Продолжительно действующие инсулинотропные пептиды |
US7144854B1 (en) | 1999-09-10 | 2006-12-05 | Conjuchem, Inc. | Long lasting anti-angiogenic peptides |
US6576610B1 (en) | 1999-10-04 | 2003-06-10 | Nuvas, Llc | Use of a context-dependent functional entity to enhance the efficacy of an agent |
AU784359B2 (en) * | 1999-12-15 | 2006-03-16 | Entremed, Inc | Compositions and methods for inhibiting endothelial cell proliferation |
FR2803207B1 (fr) * | 1999-12-30 | 2004-04-30 | Aventis Pharma Sa | Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes |
ATE303820T1 (de) * | 1999-12-30 | 2005-09-15 | Aventis Pharma Sa | Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut |
CA2415923C (en) | 2000-07-12 | 2011-10-25 | Agensys, Inc. | Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
AU8591901A (en) | 2000-09-05 | 2002-03-22 | Karolinska Innovations Ab | Materials and methods relating to endothelial cell growth inhibitors |
US20020159992A1 (en) * | 2000-09-29 | 2002-10-31 | Jack Henkin | Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
AU2002239414A1 (en) * | 2000-11-02 | 2002-05-27 | Bristol-Myers Squibb Company | Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
US20040121945A1 (en) * | 2000-12-15 | 2004-06-24 | Hong Liang | Compositions and methods for inhibiting endothelial cell proliferation |
GB0122318D0 (en) * | 2001-09-14 | 2001-11-07 | Novartis Ag | Organic compounds |
US20030211519A1 (en) * | 2001-12-19 | 2003-11-13 | Davidson Donald J. | Uses of an endothelial cell receptor |
US6818420B2 (en) * | 2002-02-27 | 2004-11-16 | Biosource International, Inc. | Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same |
US7285277B2 (en) * | 2002-03-15 | 2007-10-23 | Mogam Biotechnology Research Institute | Anticancer agent |
US20040121955A1 (en) * | 2002-04-01 | 2004-06-24 | Mulligan-Kehoe Mary Jo | Methods for modulating angiogenesis |
US20050053993A1 (en) * | 2002-12-18 | 2005-03-10 | Davidson Donald J. | Uses of an endothelial cell receptor |
US20050250694A1 (en) * | 2003-10-10 | 2005-11-10 | Ma Jian-Xing | Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same |
US20080287384A1 (en) * | 2005-09-19 | 2008-11-20 | Marsha Rosner | Methods of Identifying Agents Having Antiangiogenic Activity |
CN101356629B (zh) * | 2005-11-09 | 2012-06-06 | 高级技术材料公司 | 用于将其上具有低k介电材料的半导体晶片再循环的组合物和方法 |
US8933031B2 (en) * | 2008-02-04 | 2015-01-13 | Shanghai First People's Hospital | Polypeptide inhibiting angiogenesis and application thereof |
CA2767612A1 (en) * | 2009-07-10 | 2011-01-13 | Thrombogenics Nv | Variants of plasminogen and plasmin |
CN101974505A (zh) * | 2010-09-30 | 2011-02-16 | 西北大学 | 一种表达高活性可溶型血管生长抑制剂Kringle5三聚体工程菌的高密度发酵方法及其相应蛋白的分离纯化方法 |
US20230302102A1 (en) * | 2020-08-20 | 2023-09-28 | Talengen International Limited | Method and drug for tumor treatment |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9019120D0 (en) * | 1990-09-01 | 1990-10-17 | Beecham Group Plc | Novel compounds |
US5512591A (en) * | 1993-02-18 | 1996-04-30 | President And Fellows Of Harvard College | Treatments for diseases characterized by neovascularization |
US5469431A (en) * | 1993-07-12 | 1995-11-21 | Philips Electronics North America Corp. | Method of and apparatus for channel mapping with relative service identification |
NZ285501A (en) * | 1994-04-26 | 1998-02-26 | Childrens Medical Center | Plasminogen analogs (angiostatin), endothelial inhibitors, assays and kits |
US5639725A (en) * | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
US5854221A (en) * | 1996-12-12 | 1998-12-29 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
HUP9900979A3 (en) * | 1995-12-13 | 2001-10-29 | Children S Medical Ct Corp Bos | Endothelial cell proliferation inhibitor and method of use |
-
1996
- 1996-05-03 US US08/643,219 patent/US5801146A/en not_active Expired - Lifetime
-
1997
- 1997-04-03 US US08/832,087 patent/US5981484A/en not_active Expired - Lifetime
- 1997-05-05 CZ CZ20060013A patent/CZ300141B6/cs not_active IP Right Cessation
- 1997-05-05 CA CA2253243A patent/CA2253243C/en not_active Expired - Fee Related
- 1997-05-05 ES ES05106596T patent/ES2367307T3/es not_active Expired - Lifetime
- 1997-05-05 AT AT05106596T patent/ATE513908T1/de not_active IP Right Cessation
-
1998
- 1998-10-16 IL IL126626A patent/IL126626A/en not_active IP Right Cessation
-
1999
- 1999-10-27 HK HK06100885.2A patent/HK1082762A1/xx not_active IP Right Cessation
-
2008
- 2008-11-13 JP JP2008290560A patent/JP4722989B2/ja not_active Expired - Fee Related
- 2008-12-09 IL IL195827A patent/IL195827A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2009106290A (ja) | 2009-05-21 |
US5981484A (en) | 1999-11-09 |
ES2367307T3 (es) | 2011-11-02 |
CA2253243A1 (en) | 1997-11-13 |
CA2253243C (en) | 2010-04-06 |
CZ300141B6 (cs) | 2009-02-18 |
JP4722989B2 (ja) | 2011-07-13 |
IL126626A (en) | 2009-12-24 |
IL195827A0 (en) | 2011-08-01 |
US5801146A (en) | 1998-09-01 |
ATE513908T1 (de) | 2011-07-15 |
IL195827A (en) | 2014-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1082762A1 (en) | Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis | |
EP1612272A3 (en) | Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis | |
NZ333588A (en) | Sulphamates as anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS) | |
HK1023566A1 (en) | Process to prepare tolterodine | |
PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
GB9525692D0 (en) | Appliance for treating garments | |
PL304861A1 (en) | Butadiene-1,3 hydroformylation process | |
ZA952344B (en) | Novel protease for treating devitalized tissue | |
HK1050012A1 (en) | Peptides having antiangiogenic activity | |
AU8229887A (en) | Process for producing pig iron | |
BG103649A (en) | Method for the preparation of eprosartan | |
BG103650A (en) | Method for the preparation of eprosartan | |
ZA976854B (en) | Treatment of psychotic disorders. | |
ZA976927B (en) | Process for making pig iron. | |
AU690800B2 (en) | Improved iron carbide process | |
ZA974028B (en) | Inhibition of matrix metalloproteinases by 2(w-aroylalkyl)-4-biaryl-4-oxobutyric acids. | |
GB2352518B (en) | Screening of compunds for therapeutic activity | |
AU120212S (en) | Electric steam iron | |
AU2308397A (en) | Steam iron | |
HK1013673A1 (en) | Iron soleplate | |
ZA949786B (en) | 2,6-disubstituted change pgridyl compounds for treating psoriasis | |
HU9600379D0 (en) | Cosmetic composition, especially for treating of acne | |
NZ328739A (en) | Treatment of estrogen therapy using 8,9-dehydroesterone | |
GR1002949B (el) | Φαρμακα |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150505 |